Ionis Pharmaceuticals Inc. - MarketWatch
3 days ago · IONS | Complete Ionis Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Ionis Pharmaceuticals, Inc. Stock (IONS) - Quote Nasdaq
3 days ago · Ionis Pharmaceuticals, Inc. (IONS:NASDAQ): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Ionis Pharmaceuticals, Inc. | Nasdaq ...
Ionis to present at upcoming investor conferences | Ionis ...
Feb 25, 2025 · The Investor Relations website contains information about Ionis Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.
Resources & Information for Medical Professionals | IONIS
Click here to explore Ionis Pharmaceuticals' resources for medical professionals and learn more about RNA-targeted therapies, our medicines and pipeline.
米国Ionis Pharmaceuticals社と真性多血症治療薬「Sapablursen …
Mar 12, 2025 · 小野薬品工業株式会社（本社：大阪市中央区、代表取締役社長：滝野 十一、以下、「当社」）は、Ionis Pharmaceuticals Inc.（本社：米国、カリフォルニア州カールスバッ …
Ionis Pharmaceuticals, Inc. (IONS) - Yahoo Finance
See the company profile for Ionis Pharmaceuticals, Inc. (IONS) including business summary, industry/sector information, number of employees, business summary, corporate governance, …
IONS Ionis Pharmaceuticals, Inc. - Seeking Alpha
Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States. The company offers TRYNGOLZA reduces triglyceride levels …
On August 1, 2024, Ionis Pharmaceuticals, Inc. (the “Company”) issued a press release announcing the Company’s financial results for the quarter ended June 30, 2024.
Frank Bennett, Ph.D. - Ionis Pharmaceuticals, Inc. | LinkedIn
Dr. Bennett is the executive vice president and chief scientific officer at Ionis… · Experience: Ionis Pharmaceuticals, Inc. · Education: Baylor College of Medicine · Location: Carlsbad ...
Ionis pharmaceuticals raises 2025 revenue guidance by 20
Apr 30, 2025 · Discover Ionis Pharmaceuticals' stellar Q1 2025 earnings: TRYNGOLZA's strong debut, raised revenue guidance, and strategic milestones propel growth.
Isis Pharmaceuticals Achieves Milestone in Antisense Drug …
Apr 21, 2003 · The Investor Relations website contains information about Ionis Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.
Ionis announces appointment of Joan E. Herman to its board of directors Carlsbad, Calif., June 12, 2019 – Ionis Pharmaceuticals, Inc. (Nasdaq: IONS), the leader in RNA-targeted …
Ionis poised for continued momentum in 2024 with product …
Jan 8, 2024 · /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced highlights from the Company's 2023 achievements and previewed a number of important...
Redirecting to https://ir.ionis.com/newsroom/press-releases
Redirecting to https://ir.ionis.com/newsroom/press-releasesRedirecting to https://ir.ionis.com/newsroom/press-releases.
Ionis reports second quarter financial results and recent business ...
Aug 9, 2022 · The Investor Relations website contains information about Ionis Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.
Ionis Pharmaceuticals, Inc. busca personal para el cargo de …
Ionis Pharmaceuticals, Inc. ha indicado el rango de sueldo Este rango lo ha facilitado Ionis Pharmaceuticals, Inc.. El sueldo real dependerá de tus aptitudes y experiencia. Pide …
Ionis announces expanded licensing agreement with Otsuka in …
CARLSBAD, Calif., June 18, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that it has entered into a license agreement with Otsuka Pharmaceutical …
Ono Enters into License Agreement with Ionis Pharmaceuticals …
Osaka, Japan, March 12, 2025 - Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “ONO”) announced that it has entered into a license …
IONS.OQ - | Stock Price & Latest News | Reuters
6 days ago · Get Ionis Pharmaceuticals Inc (IONS.OQ) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments
Ionis Pharmaceuticals, Inc. Company Overview, Contact Details
Mar 26, 2025 · Learn more about Ionis Pharmaceuticals, Inc.'s company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a …
On February 21, 2024, Ionis Pharmaceuticals, Inc. (the “Company”) issued a press release announcing the Company’s financial results for the quarter and fiscal year ended December …
Ionis Pharmaceuticals, Inc. Email Format | ionisph.com Emails
The most common Ionis Pharmaceuticals, Inc. email format is [first_initial] [last] (ex. [email protected]), which is being used by 99.0% of Ionis Pharmaceuticals, Inc. work email …
Ionis Pharmaceuticals, Inc. Company Profile & Data: stocks, …
Jan 1, 2025 · Company Profile of Ionis Pharmaceuticals, Inc. with information on the company's activities, financials, digital presence, market capitalization, stocks and stock …
Ionis Pharmaceuticals, Inc. Management Team | Org Chart
Ionis Pharmaceuticals, Inc. employs 1,244 employees. The Ionis Pharmaceuticals, Inc. management team includes Brett Monia (Chief Executive Officer), Shannon Devers (Executive …
IONS | Ionis Pharmaceuticals Inc. Stock Overview (U.S.: Nasdaq ...
Complete Ionis Pharmaceuticals Inc. stock information by Barron's. View real-time IONS stock price and news, along with industry-best analysis.
Ionis Pharmaceuticals (IONS) Moves 9.1% Higher: Will This …
3 days ago · Ionis Pharmaceuticals (IONS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock …
Ionis Pharmaceuticals - ZoomInfo.com
View Ionis Pharmaceuticals (www.ionis.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …
Ionis reports third quarter 2023 financial results
Nov 2, 2023 · The Investor Relations website contains information about Ionis Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.
Our Responsibility to Create a Healthier Future | IONIS
Our Approach to Corporate Responsibility At Ionis, we work with a sense of urgency to discover, develop and deliver medicines to create a better future for people with serious diseases. We …
Ionis Pharmaceuticals Inc (IONS) 10K Annual Reports & 10Q SEC …
Feb 19, 2025 · Analyze up to 10 years of full 10K Annual Reports and Quarterly 10Q SEC filings for Ionis Pharmaceuticals Inc (IONS) using our online tools.
About Ionis Pharmaceuticals, Inc. For more than 30 years, Ionis has been a leader in RNA-targeted therapy, pioneering new markets and changing standards of care. Ionis currently has …
Ionis announces new chief global product strategy officer to lead …
Feb 29, 2024 · About Ionis Pharmaceuticals, Inc. For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has five marketed …
0000874015-25-000137 | 4 | Ionis Pharmaceuticals, Inc.
5 days ago · The Investor Relations website contains information about Ionis Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.
Innovating to Change the Course of Human Health | IONIS
Ionis is continually advancing the design, screening, and development of its investigational RNA-targeted therapeutics to optimize the selection of investigational therapeutics for neurologic …
Ionis Pharmaceuticals, Inc. - Company Profile & Staff Directory ...
Ionis Pharmaceuticals, Inc. is a Biotechnology company located in 2855 Gazelle Ct, Carlsbad, CA 92010, US with 1,121 employees. Access Ionis Pharmaceuticals, Inc.'s email format and Ionis …
Apply for a Career at Ionis Pharmaceuticals | IONIS
Join Ionis Pharmaceuticals for competitive benefits, growth opportunities, and a commitment to diversity. Explore our rewarding career options here.
Zilganersen granted U.S. FDA Fast Track designation for people …
Oct 1, 2024 · /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that the U.S. Food and Drug Administration (FDA) has granted zilganersen Fast Track...
SEC Filings | Ionis Pharmaceuticals, Inc.
4 days ago · The Investor Relations website contains information about Ionis Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.
Ionis reports fourth quarter and full year 2020 financial results and ...
Feb 24, 2021 · The Investor Relations website contains information about Ionis Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.
IONS | Ionis Pharmaceuticals Inc. Profile | MarketWatch
Ionis Pharmaceuticals Inc. Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology.
Ionis enters collaboration to advance next generation program …
Aug 3, 2023 · The Investor Relations website contains information about Ionis Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.
IONS: Ionis Pharmaceuticals Inc Stock Price Quote - Bloomberg
Stock analysis for Ionis Pharmaceuticals Inc (IONS:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Ionis Pharmaceuticals, Inc. (IONS) Earnings Call Transcripts
3 days ago · All earnings call transcripts on Ionis Pharmaceuticals, Inc. (IONS) stock. Read or listen to the conference call. Download the investor presentation - earnings call slides.
Ionis Pharmaceuticals Reports Strong Q4 Earnings After Recent …
Feb 19, 2025 · Ionis Pharmaceuticals beats Q4 earnings, eyes sHTG market with TRYNGOLZA. Strong pipeline and cash position make it a must-watch. Read more on IONS stock here.
Ionis and Akcea Enter into Strategic Collaboration with Global ...
Jan 6, 2017 · CARLSBAD, Calif. and CAMBRIDGE, Mass., Jan. 6, 2017 /PRNewswire/ -- Ionis Pharmaceuticals Inc. (NASDAQ: IONS) and Akcea Therapeutics, a wholly-owned subsidiary of …
Sumitomo Mitsui Trust Group Inc. Sells 14,224 Shares of Ionis ...
1 day ago · Sumitomo Mitsui Trust Group Inc. decreased its holdings in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 9.1% in the 1st quarter, according to …
IONIS PHARMACEUTICALS, INC. Company Profile | Carlsbad, CA ...
Find company research, competitor information, contact details & financial data for IONIS PHARMACEUTICALS, INC. of Carlsbad, CA. Get the latest business insights from Dun & …
Teacher Retirement System of Texas Increases Holdings in Ionis ...
1 day ago · Teacher Retirement System of Texas grew its holdings in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 660.7% in the first quarter, according …